We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Treatt Plc | LSE:TET | London | Ordinary Share | GB00BKS7YK08 | ORD 2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 475.50 | 1,000 | 08:08:48 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 468.50 | 483.00 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 147.4M | 10.94M | 0.1809 | 26.12 | 285.74M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 08:02:24 | O | 1,000 | 466.3455 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 10/4/2024 | 09:01 | ALNC |  Treatt to meet full-year profit expectations despite fall in revenue |
| 10/4/2024 | 07:00 | UK RNS | Treatt PLC Half Year Trading Update & Notice of Results |
| 19/3/2024 | 15:40 | UK RNS | Treatt PLC Notification of Transactions of Directors |
| 04/3/2024 | 12:14 | ALNC | IN BRIEF: Treatt appoints David Shannon as new CEO |
| 04/3/2024 | 07:00 | UK RNS | Treatt PLC Appointment of Chief Executive Officer |
| 13/2/2024 | 09:35 | UK RNS | Treatt PLC Holding(s) in Company |
| 31/1/2024 | 14:41 | UK RNS | Treatt PLC Notification of Transaction of PDMR |
| 25/1/2024 | 20:21 | ALNC | TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up |
| 25/1/2024 | 15:49 | UK RNS | Treatt PLC Result of AGM |
| 25/1/2024 | 07:00 | UK RNS | Treatt PLC AGM Trading Update |
Treatt (TET) Share Charts1 Year Treatt Chart |
|
1 Month Treatt Chart |
Intraday Treatt Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 15/4/2024 | 17:39 | Treatt Thread With Charts | 1,031 |
| 16/8/2022 | 15:38 | Treatt -- interim financial results: anyone seen them? | 17 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 07:02:24 | 466.35 | 1,000 | 4,663.46 | O |
| 06:15:04 | 475.17 | 400 | 1,900.66 | O |
| 06:15:04 | 470.50 | 4 | 18.82 | O |
| 06:15:04 | 469.34 | 855 | 4,012.84 | O |
| 2024-04-15 16:24:26 | 465.04 | 9,506 | 44,206.23 | O |
| Top Posts |
|---|
Posted at 16/4/2024 09:20 by Treatt Daily Update Treatt Plc is listed in the Chemicals & Chem Preps, Nec sector of the London Stock Exchange with ticker TET. The last closing price for Treatt was 475.50p.Treatt currently has 60,473,882 shares in issue. The market capitalisation of Treatt is £285,739,092. Treatt has a price to earnings ratio (PE ratio) of 26.12. This morning TET shares opened at - |
Posted at 15/4/2024 14:39 by ottrott Glanbia paid $300m, Flavor Producers adjusted EBITDA $19.7m for 12 months to 2/24, in comparison TET current valuation £285m adjusted EBITDA £25.9m FY24 estimate. So Glanbia paid roughly 36% over TET valuation. |
Posted at 10/4/2024 11:28 by essentialinvestor Congrats to those who added at the open, I hesitated at the opening offer price. |
Posted at 10/4/2024 09:11 by viscount1 Some rapid short covering now pushing the price up. |
Posted at 18/3/2024 13:41 by essentialinvestor Long-standing CEO exits, now price drifting.. I'm not suggesting something specific, just an observation. |
Posted at 04/3/2024 08:26 by james188 I much prefer the way that the CEI succession issue has been handled at another nearby AIM company - Tristel. There, the outgoing CEO is staying on until his successor is in post and planned revised targets for the company have been deferred until after tha new CEO has had the opportunity to participate in the process. I think that the acting CEO has done a decent job, but about the only good things I can say about the TET process is that it was completed quickly and the new CEO has a decent CV. |
Posted at 29/2/2024 17:21 by essentialinvestor cfro, thanks for the view - I would just add that for many years TET sold around 13-14X (from memory) - ZIRP altered this.It's now a larger business and arguably also higher quality tbf. |
Posted at 29/2/2024 12:37 by pireric I always like to use the method of "If there was no share price chart, would I still buy the stock here?"I'd still be concerned that a profit warning would put this on 20x+ earnings, which while still a big discount to the other players in the industry, wouldn't likely be taken by the market well. Nor is there a permanent CEO or CFO in place. I suspect this is what the market is thinking, and hence hanging fire on. Eric |
Posted at 19/2/2024 13:07 by partridge1948 In my dreams we have an RNS confirming the two appointments and advising of trading ahead of expectations. (Share price currently suggests this is highly unlikely!) |
Posted at 24/12/2023 14:57 by cfro loofyloofy,I was just curious to look back through some your previous posts on Treatt and quickly came across your post from way back in March 9th 2016 (please forgive me for being nosey!). In it you made a direct comparison to Symrise. A transcript of your post below: Symrise´s results came out yesterday - herewith some comprisons: EPS 1.90 euros per share 11.94 pence Dividend 80 cents per share 4.04 pence EBITDA Margin 22% 11.77% Net margin 9.49% 9.3% Share price 55.90 euros 175 pence Price/earnings ratio 29.42 14.66 Dividend yield 1.4% 2.3% Dividend cover 2.37 2.95 Interesting......I am not so sure the Symrise results were that good..on every other metric, apart from EBITDA, they are lower than Treatt. Net margins almost identical. It just struck me. I have not looked at Symrise and currently don't have the time right now (it's Christmas!) to see where the comparison might stand today, but reading your post above it sounds like you do at least keep an eye on Treatt's higher rated competitors. |
Posted at 22/12/2023 13:40 by sleepy partridge - I think the main reason for the drop in share price has been that the market put the shares on an extremely optimistic rating which has not, at least as yet, been justified. Not the company’s fault |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
